Zhou Songyang

Baylor College of Medicine

Papers

1

Total Citations

235

H-Index

1

About

Zhou Songyang is a leading figure in molecular biology, best known for his pioneering work on protein phosphorylation and signal transduction. His research has fundamentally advanced our understanding of how phosphorylation events orchestrate cellular signaling, particularly through the identification and characterization of phosphopeptide-binding domains. In his highly cited 2003 study on the BRCA1 COOH-terminal (BRCT) domains, Songyang demonstrated that these domains function as phosphoserine/phosphothreonine-binding modules, revealing a critical mechanism for assembling DNA damage repair complexes. This work, with over 235 citations, has had a profound impact on cancer biology by linking phosphorylation-dependent interactions to tumor suppression. Beyond BRCT domains, Songyang has made seminal contributions to the study of telomeres and telomerase, elucidating how these structures maintain genomic stability. His research consistently bridges basic mechanistic insights with implications for human disease, particularly cancer and aging. With a career spanning over two decades, Songyang’s discoveries have shaped the fields of cell signaling and genome integrity, earning him recognition as a thought leader whose work continues to inspire new generations of researchers.

Research Focus

Key Achievements

1
H-Index
1
Papers
235
Total Citations
235
Avg Citations/Paper
🏆 Most Cited Paper
Phosphopeptide Binding Specificities of BRCA1 COOH-terminal (BRCT) Domains
235 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Baylor College of Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago